Location History:
- Toronto, CA (2014 - 2017)
- North York, CA (2017 - 2019)
Company Filing History:
3 out of 51 
1 out of 291 
1 out of 77 
Years Active: 2014-2019
Title: Geneve Sheandra Awong: Innovator in Hematopoietic Stem Cell Research
Introduction
Geneve Sheandra Awong is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of hematopoietic stem cell research, holding a total of 4 patents. Her work focuses on the differentiation and application of human progenitor T-cells, which have important implications for immunotherapy and gene therapy.
Latest Patents
Among her latest patents is a groundbreaking invention involving human progenitor T-cells that can successfully engraft a murine thymus and differentiate into mature human T and NK cells. These progenitor T-cells, characterized by the phenotype CD34+CD7+CD1a−CD5− or CD34+CD7+CD1a−CD5+, are derived from human hematopoietic stem cells, embryonic stem cells, and induced pluripotent stem cells through coculture with cells expressing a Notch receptor ligand. This innovation is particularly useful for immune reconstitution and the treatment of immunodeficiencies. Another notable patent describes a method for enriching a population of stem cells for hematopoietic progenitors, which involves inducing hematopoietic differentiation in human embryonic or induced pluripotent stem cells and sorting based on specific markers.
Career Highlights
Geneve has worked with esteemed institutions such as Sunnybrook Health Sciences Centre and University Health Network. Her research has been pivotal in advancing the understanding of stem cell biology and its applications in medicine.
Collaborations
Geneve has collaborated with notable colleagues in her field, including Juan Carlos Zuniga-Pflucker and Ross La Motte-Mohs. Their joint efforts have contributed to the advancement of innovative techniques in stem cell research.
Conclusion
Geneve Sheandra Awong is a trailblazer in the field of hematopoietic stem cell research, with a focus on developing innovative therapies for immunodeficiencies. Her contributions continue to shape the future of regenerative medicine.